Document Detail


Digoxin increases peripheral chemosensitivity and the ventilatory response to exercise in normal subjects.
MedLine Citation:
PMID:  19719746     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. The contribution of peripheral chemoreceptors to the regulation of ventilation during exercise remains incompletely understood. Digoxin has been reported to increase chemoreflex sensitivity in humans. In the present randomized, cross-over, double-blind study, we tested the hypothesis that this increases the ventilatory response to exercise in normal subjects, as assessed by changes in minute ventilation (V(E)) in response to the rate of CO(2) production (VCO(2)). 2. Minute ventilation, end-tidal PCO(2), pulse oximetric O(2) saturation (S(p)O(2)), heart rate and blood pressure (BP) were measured in 11 healthy young male untrained subjects after intravenous infusion of digoxin (0.01 mg/kg) or placebo during normoxia, isocapnic hypoxia and hyperoxic hypercapnoea. All participants underwent a maximum cardiopulmonary exercise test. 3. During normoxia, digoxin increased systolic BP only. During hypoxia, digoxin increased V(E) compared with placebo (P = 0.009) for the same fall in S(p)O(2) (P = NS). Moreover, no significant effects on ventilation and haemodynamic responses were recorded during hypercapnoea. Digoxin increased the V(E) /VCO(2) slope above the anaerobic threshold from 30.4 +/- 2.9 to 32.8 +/- 3.7 (P < 0.05), but did not affect VO(2max). 4. In conclusion, enhanced peripheral chemosensitivity with digoxin increases the ventilatory response to CO(2) production above the anaerobic threshold, but does not affect exercise capacity in healthy humans.
Authors:
C Janssen; O Lheureux; S Beloka; G Deboeck; D Adamopoulos; R Naeije; P van de Borne
Related Documents :
15258116 - Peripheral chemoreceptor control of ventilation following sustained hypoxia in young an...
11438386 - Excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lac...
10233116 - Peripheral chemoreceptor function after carbonic anhydrase inhibition during moderate-i...
17705796 - Vascular adaptations to hypoxia: molecular and cellular mechanisms regulating vascular ...
16244066 - Determination and evaluation of an optimal dosage of carfentanil and xylazine for the i...
17106066 - Blunted lipolysis and fatty acid oxidation during moderate exercise in hiv-infected sub...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-08-28
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  37     ISSN:  1440-1681     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-04-22     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  303-8     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Erasme University Hospital, Brussels, Belgium. chrisrv.janssen@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / drug effects,  physiology
Chemoreceptor Cells / physiology*
Cross-Over Studies
Digoxin / pharmacology*
Double-Blind Method
Exercise / physiology*
Heart Rate / drug effects,  physiology
Humans
Male
Pulmonary Ventilation / drug effects*,  physiology*
Young Adult
Chemical
Reg. No./Substance:
20830-75-5/Digoxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Confidence in Altman-Bland Plots: A Critical Review of the Method of Differences.
Next Document:  Ginsenoside Rd prevents glutamate-induced apoptosis in rat cortical neurons.